CoChat

Health Care Spending on Diabetes in the U.S., 1996–2013

Open access
Squires, Ellen, Duber, Herbert, Campbell, Madeline, Cao, Jackie, Chapin, Abigail, Horst, Cody, Li, Zhiyin, Matyasz, Taylor, Reynolds, Alex, Hirsch, Irl B., Dieleman, Joseph L. · 2018 · Diabetes Care
Cited by 40

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Health care spending on diabetes in the U.S. has increased dramatically over the past several decades. This research describes health care spending on diabetes to quantify how that spending has changed from 1996 to 2013 and to determine what drivers are increasing spending. RESEARCH DESIGN AND METHODS: Spending estimates were extracted from the Institute for Health Metrics and Evaluation’s Disease Expenditure 2013 database. Estimates were produced for each year from 1996 to 2013 for each of 38 age and sex groups and six types of care. Data on disease burden were extracted from the Global Burden of Disease 2016 study. We analyzed the drivers of spending by measuring the impact of population growth and aging and changes in diabetes prevalence, service utilization, and spending per encounter. RESULTS: Spending on diabetes in the U.S. increased from $37 billion (95% uncertainty interval $32–$42 billion) in 1996 to $101 billion ($97–$107 billion) in 2013. The greatest amount of health care spending on diabetes in 2013 occurred in prescribed retail pharmaceuticals (57.6% [53.8–62.1%] of spending growth) followed by ambulatory care (23.5% [21.7–25.7%]). Between 1996 and 2013, pharmaceutical spending increased by 327.0% (222.9–456.6%). This increase can be attributed to changes in demography, increased disease prevalence, increased service utilization, and, especially, increases in spending per encounter, which increased pharmaceutical spending by 144.0% (87.3–197.3%) between 1996 and 2013. CONCLUSIONS: Health care spending on diabetes in the U.S. has increased, and spending per encounter has been the biggest driver. This information can help policy makers who are attempting to control future spending on diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc17-1376

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 11

  1. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators, 2017, Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016, Lancet, 390, 1211, 10.1016/S0140-6736(17)32154-2 · DOI · Paper page
  2. Dunn A, Liebman E, Shapiro AH. Decomposing medical-care expenditure growth [Internet], 2012. Available from http://www.frbsf.org/economic-research/files/wp12-26bk.pdf. Accessed 1 February 2017 · doi:10.3386/w23117
  3. Newhouse, 1993, An iconoclastic view of health cost containment, 152
  4. Smith, 2009, Income, insurance, and technology: why does health spending outpace economic growth, Health Aff (Millwood), 28, 1276, 10.1377/hlthaff.28.5.1276 · DOI · Paper page
  5. Starr, 2014, Decomposing growth in spending finds annual cost of treatment contributed most to spending growth, 1980-2006, Health Aff (Millwood), 33, 823, 10.1377/hlthaff.2013.0656 · DOI · Paper page
  6. Dieleman, 2017, Adjusting health spending for the presence of comorbidities: an application to United States national inpatient data, Health Econ Rev, 7, 30, 10.1186/s13561-017-0166-2 · DOI
  7. Flaxman, 2015, An Integrative Metaregression Framework for Descriptive Epidemiology
  8. Das Gupta, 1991, Decomposition of the difference between two rates and its consistency when more than two populations are involved, Math Popul Stud, 3, 105, 10.1080/08898489109525329 · DOI
  9. Hirshberg, 2013, Cardiovascular outcome studies with novel antidiabetes agents: scientific and operational considerations, Diabetes Care, 36, S253, 10.2337/dcS13-2041 · DOI
  10. Hua, 2016, Expenditures and prices of antihyperglycemic medications in the United States: 2002-2013, JAMA, 315, 1400, 10.1001/jama.2016.0126 · DOI · Paper page
  11. Halter, 2012, Diabetes mellitus in an aging population: the challenge ahead, J Gerontol A Biol Sci Med Sci, 67, 1297, 10.1093/gerona/gls201 · DOI

Cited by

See all 40

Metadata

Authors
Squires, E., Duber, H., Campbell, M., Cao, J., Chapin, A., Horst, C., Li, Z., Matyasz, T., Reynolds, A., Hirsch, I. B., & Dieleman, J. L.
Venue
Diabetes Care
Published
2018-05-10
Volume
41
Issue
7
Pages
1423-1431
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2801742794
Cited by
40
References
5
FWCI
7.15
Type
journal article
Language
en
Open access
bronze
Funders
  • The Peterson Center on Healthcare (16020)
  • National Institute on Aging (P30-AG-047845)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.